Autologous NK cell therapy (Yuantian Bio)

自体NK细胞疗法（原天生物）

Report date: 2025/05/09 11:22:14

Base Information

Drug NameAutologous NK cell therapy (Yuantian Bio)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSarcoidosis, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Yuantian Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Tenth People'S Hospital
Inactive CompaniesN/A
Active IndicationsSarcoidosis, Pulmonary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A